Researchers in San Jose’ Costa Rica plan to begin clinical trials in human subjects of a novel, and inexpensive, treatment for Coronavirus that is based on antibodies taken from horses injected with the SARS-Cov-2 (the virus that causes COVID-19), according to the Spokesperson of the Costa Rica’s Clodomiro Picado Institute (ICP).
“This novel approach to vaccine development is based on a medication derived from equine antibodies is scheduled to be tested on 26 patients in mid-September”, said Roman Macaya, President of the Social Security Fund that manages public health centers. “We did it with our resources, without having to stand in-line, or compete with other countries” added Macaya.
The Ministry of Health hopes to deploy the treatment if the results from the Phase-2 Trial produce good outcomes. At the present time, some 470 Covid-19 cases are hospitalized in Costa Rica.
Similar efforts are also underway in Argentina and Brazil, while scientists in Belgium are using llamas.
Source: The New York Times